Nurix Therapeutics (NRIX) Research & Development: 2019-2025
Historic Research & Development for Nurix Therapeutics (NRIX) over the last 6 years, with Aug 2025 value amounting to $86.1 million.
- Nurix Therapeutics' Research & Development rose 55.22% to $86.1 million in Q3 2025 from the same period last year, while for Aug 2025 it was $301.1 million, marking a year-over-year increase of 47.51%. This contributed to the annual value of $221.6 million for FY2024, which is 17.17% up from last year.
- As of Q3 2025, Nurix Therapeutics' Research & Development stood at $86.1 million, which was up 10.27% from $78.1 million recorded in Q2 2025.
- Nurix Therapeutics' 5-year Research & Development high stood at $86.1 million for Q3 2025, and its period low was $23.0 million during Q1 2021.
- Its 3-year average for Research & Development is $58.6 million, with a median of $50.0 million in 2024.
- Its Research & Development has fluctuated over the past 5 years, first spiked by 87.53% in 2022, then dropped by 3.64% in 2023.
- Quarterly analysis of 5 years shows Nurix Therapeutics' Research & Development stood at $36.5 million in 2021, then rose by 26.21% to $46.1 million in 2022, then increased by 7.82% to $49.7 million in 2023, then soared by 35.22% to $67.2 million in 2024, then skyrocketed by 55.22% to $86.1 million in 2025.
- Its last three reported values are $86.1 million in Q3 2025, $78.1 million for Q2 2025, and $69.7 million during Q1 2025.